> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Lupin Recalls Contraceptive Over Packaging Error
- URL: https://www.fdaweb.com/lupin-recalls-contraceptive-over-packaging-error/
- Published: 2017-05-31T12:00:00.000Z
- Updated: 2026-09-14T22:26:32.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5138827

Lupin Pharmaceuticals has recalled one lot (# L600518, Exp 05/18) of Mibelas 24 Fe (norethindrone acetate and ethinyl estradiol) 1 mg/0.02 mg chewable and ferrous fumarate 75 mg tablets due to a complaint about a packaging error. The company says the contraceptive blister pack, when rotated 180 degrees within the wallet, reverses the weekly tablet orientation. When this occurs, the first four days of therapy would have had four non-hormonal placebo tablets as opposed to the active tablets, according to a [recall notice](https://www.fda.gov/Safety/Recalls/ucm560904.htm?ref=fdaweb.com). “As a result of this packaging error, oral contraceptive tablets that are taken out of sequence may place the user at risk for contraceptive failure and unintended pregnancy,” it says.